The “it’s the prices” narrative focuses attention on a set of fee-schedule-oriented policies (some of which, as noted above, I support). The concern I have is that this narrative focuses attention ...

With a growing demand for mental health and substance use disorder services, states should think creatively about policies to extend and grow the workforce.

Renee Gross, JD, is the community behavioral health initiatives lead for Kaiser Permanente.

Multi-year coverage potentially improves the value of insurance by making it easier for insurers to pool high- and low-risk ...

While the value of HF/SE in improving patient safety has been demonstrated, the field remains significantly underused and not well understood. 9 In this article we describe HF/SE, its different facets ...

Maryland hospitals have operated under all-payer global budget models since 2014. Within Medicare, evaluations have estimated the resulting cost savings to be $1.6 billion for the period 2014–22. To ...

The FDA should improve device safety by increasing the amount and availability of information about previously marketed ...

The US pays higher drug prices than do peer nations, thereby financing a disproportionate share of global pharmaceutical research and development. President Donald Trump has announced himself willing ...

By addressing the missing link of clinician engagement and providing financial tools and regulatory freedom to innovate, ...

This article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician, hospital, and other health care provider ...

During the past two decades in the United States, all major payer types—commercial, Medicare, Medicaid, and multipayer coalitions—have introduced value-based purchasing (VBP) contracts to reward ...

Medicare’s opioid treatment benefit unintentionally encourages underuse of psychosocial services. The authors propose a ...